Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

Learn what the Nipah virus is, how it spreads, and why it has one of the highest fatality rates among infectious diseases.

In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab ...

Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. [Operator Instructions] Please be ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...

DTAB recommends amendment of PSUR reporting period norms under NDCT Rules: Gireesh Babu, New Delhi Tuesday, April 7, 2026, 08:00 Hrs [IST] The Drugs Technical Advisory Board (DTAB ...

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

Hørsholm, Denmark, 7 April 2026 - The Board of Directors of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") has today, on 7 April 2026, pursuant to the authorization granted by th ...

It seems that every time we start to relax, a new Covid-19 variant surfaces. Covid-19 fatigue is real, and many people just aren’t paying attention ...

Learn more about whether Halozyme Therapeutics, Inc. or Relay Therapeutics, Inc. is a better investment based on AAII's A+ ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...